How to manage a blood glucose level of 244?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Blood Glucose Level of 244 mg/dL

For a blood glucose level of 244 mg/dL, you should contact the provider as soon as possible and initiate or adjust glucose-lowering therapy, as this exceeds the threshold requiring intervention according to American Diabetes Association guidelines. 1

Immediate Assessment Required

  • Evaluate the clinical context to determine urgency of intervention: assess for symptoms of hyperglycemia (polyuria, polydipsia, altered mental status, dehydration), check vital signs, and determine if the patient is acutely ill or has any comorbid conditions 2

  • Rule out hyperglycemic crisis by checking for ketones in urine or blood, particularly if the patient has type 1 diabetes or presents with nausea, vomiting, or abdominal pain 2

  • Assess for precipitating factors including infection, medication non-adherence, new medications (especially corticosteroids), or acute illness that may be driving the hyperglycemia 1

Treatment Algorithm Based on Clinical Setting

For Hospitalized Patients

  • Target glucose range of 140-180 mg/dL for most hospitalized patients, which balances glycemic control with hypoglycemia risk 1, 2

  • Initiate basal-bolus insulin regimen for non-critically ill patients with adequate oral intake: start with basal insulin (NPH, glargine, or detemir) combined with rapid-acting prandial insulin before meals 1, 2

  • Use basal insulin alone for patients with poor oral intake or those receiving nothing by mouth, avoiding sliding-scale insulin as monotherapy which is strongly discouraged 1

  • Monitor blood glucose before each meal and at bedtime (or every 4-6 hours if not eating) to guide insulin dose adjustments 1

For Outpatients or Long-Term Care Residents

  • Contact the provider as soon as possible when glucose values exceed 250 mg/dL within a 24-hour period, as this meets the threshold for urgent notification 1

  • Initiate or intensify therapy with subcutaneous insulin if not already prescribed, starting with basal insulin and adding prandial coverage as needed 2

  • For patients with type 2 diabetes not on insulin, consider starting basal insulin while continuing metformin (if renal function permits), then add prandial insulin if hyperglycemia persists 2

Monitoring Strategy

  • Check blood glucose every 1-2 hours initially if starting insulin therapy until values stabilize, then every 4 hours thereafter 1

  • Adjust insulin doses daily based on blood glucose patterns rather than relying on reactive sliding-scale corrections alone 2

  • Use point-of-care capillary testing with caution as these measurements may not accurately reflect arterial or plasma glucose values; consider arterial blood if available 1

Critical Pitfalls to Avoid

  • Never use sliding-scale insulin alone without basal insulin coverage, as this approach is ineffective and increases risk of both hyperglycemia and hypoglycemia 1, 2

  • Do not delay insulin therapy when glucose levels are markedly elevated (>240 mg/dL), as this increases risk of progression to hyperglycemic crisis 2

  • Avoid tight glucose control targeting levels below 140 mg/dL in hospitalized patients, as this increases hypoglycemia risk without improving outcomes 1

  • Review and adjust the regimen whenever implementing changes in nutrition status, as nutrition-insulin mismatch is a common cause of both hyperglycemia and hypoglycemia 1

Special Populations

  • For older adults in palliative care, preventing hypoglycemia takes priority over tight control; allow glucose values in the upper range of 180-250 mg/dL to avoid hypoglycemic events 1

  • For critically ill patients, use continuous intravenous insulin infusion based on validated protocols, targeting glucose <180 mg/dL 1, 2

  • When transitioning from IV to subcutaneous insulin, start subcutaneous basal insulin at 60-80% of the daily IV insulin dose, administered 1-2 hours before discontinuing the infusion 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.